?> Ifosfamide (Holoxan) and Mesna: Why They Go Together
1800 202 8726

HomeChemotherapy › Ifosfamide (Holoxan) and Mesna: — Why They Go Together

Chemotherapy drug

Ifosfamide (Holoxan) and Mesna: Why They Go Together

Medically reviewed by Dr. Naresh Gundu, Medical Oncologist, MBBS (Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar) · DNB Internal Medicine (Sir Gangaram Hospital, New Delhi) · DM Medical Oncology (AIIMS) · Last reviewed September 2026

Ifosfamide is always prescribed alongside a second medicine called mesna. Mesna is not a chemotherapy agent — it exists for one reason only: to protect your bladder from a toxic byproduct that ifosfamide produces as it breaks down.

Prescription-only medicine.

Ifosfamide and mesna are prescription-only medicines given by intravenous infusion under specialist oncology supervision in a hospital setting. Neither medicine can be started, adjusted, or discontinued on the basis of anything read online or outside a formal clinical assessment. It is not suitable for everyone — see who this is not for below.

Talk to an oncologist

Leave your details and a member of the oncology team will call you back to answer questions about your treatment plan.

No charge for the call, and no obligation to book anything.
412Chemotherapy pages, written and reviewed
17Oncologists on the panel
10Centres across Hyderabad
41Locations across two states

In short

Mesna is given with ifosfamide to protect the bladder. Ifosfamide produces a toxic breakdown product called acrolein that damages the bladder lining. Mesna travels to the bladder and neutralises acrolein before it can cause harm. The two are always prescribed together — mesna has no effect on the cancer itself.

In detail

What is ifosfamide (Holoxan)?

Ifosfamide — prescribed in India under the brand name Holoxan, among others — is a chemotherapy medicine that works by damaging the DNA inside cancer cells so they cannot divide and multiply. It belongs to a class called alkylating agents.

It is given by intravenous infusion in a hospital or day-care setting. It is not available as a tablet and is not self-administered at home.

Ifosfamide is used for a range of cancer types. Your oncologist will explain which cancer is being treated and why this medicine has been chosen for your specific situation.

In detail

Why is mesna given with ifosfamide?

When the body breaks down ifosfamide, one of the byproducts is a substance called acrolein. Acrolein is filtered into the urine and, while it sits in the bladder, can damage the bladder lining — a condition called haemorrhagic cystitis, which causes bleeding and pain.

Mesna is not a chemotherapy medicine. It is a protective agent that concentrates in the urine and binds to acrolein before it can reach the bladder wall, making it inactive and safe to pass out of the body.

The two medicines are always prescribed together. Receiving ifosfamide without mesna is not standard practice. If your treatment plan includes both, that is exactly what is expected.

Eligibility

Who is ifosfamide not suitable for?

Ifosfamide is not appropriate for all patients. Your oncologist decides whether it is suitable for you based on your full clinical picture.

  • Have significantly impaired kidney function, as the kidneys clear ifosfamide and its toxic breakdown products
  • Have significantly impaired liver function, which can affect how the medicine is metabolised
  • Have a urinary tract obstruction or pre-existing severe bladder damage
  • Have had a previous severe or life-threatening reaction to ifosfamide or closely related medicines
  • Are pregnant, or for whom pregnancy cannot be excluded
  • Have bone marrow suppression severe enough to make further blood count falls unacceptably dangerous

Age, general fitness, heart function, and the presence of other illnesses also affect whether ifosfamide is appropriate. Eligibility is decided by an oncologist on the individual case, not by the diagnosis alone.

Want to talk this through with an oncologist?

Leave your number and an oncology coordinator will call you back at a time that suits you.

One call. No cost and no obligation.

In detail

Why does ifosfamide sometimes cause confusion?

A proportion of patients treated with ifosfamide develop a temporary change in brain function called ifosfamide-induced encephalopathy. This can range from mild drowsiness and confusion to disorientation, unusual behaviour, or hallucinations.

This is not ordinary tiredness from chemotherapy. New confusion or unusual behaviour during ifosfamide treatment is a symptom to report to your treating team the same day — it does not resolve on its own in the way fatigue does.

Tell your team immediately if someone on ifosfamide becomes confused, difficult to wake, starts saying things that do not make sense, or has a seizure. Treatment is available, and prompt recognition changes the outcome.

Question by question

Other questions about ifosfamide and mesna

Does mesna protect against all of ifosfamide's side effects?

No. Mesna is specific to bladder protection. It neutralises acrolein in the urine before it can damage the bladder lining, and that is its only job. It has no effect on ifosfamide's other possible side effects, which include a fall in blood cell counts, nausea, hair thinning or loss, kidney effects, and the brain effects described on this page. Those are monitored and managed by your oncology team through regular blood tests, supportive medicines, and clinical assessment.

What other side effects can ifosfamide cause?

Beyond bladder damage and the brain effects already described, ifosfamide commonly causes a drop in blood cell counts — which increases vulnerability to infection, bleeding, and anaemia. Nausea, hair thinning or loss, and effects on kidney function are also reported. Your oncology team monitors blood counts and kidney function regularly during treatment and will explain what to watch for between appointments before your first infusion. Report any sign of infection — a temperature, shivering, or feeling suddenly much worse — the same day, not at your next scheduled visit.

Can the brain effects of ifosfamide be treated?

Yes. Ifosfamide-induced encephalopathy is usually reversible, and your medical team can treat it. The key is recognising it early. If confusion, unusual drowsiness, disorientation, slurred speech, or any seizure appears during or after ifosfamide treatment, tell your treating team the same day — do not wait to see whether it resolves on its own. Once the symptoms are identified and the clinical team has assessed and managed the cause, most patients recover. Delay is what changes the outcome.

Will I need to take mesna tablets at home?

Sometimes, yes. Mesna can be given as an intravenous infusion in hospital and then continued as tablets to take at home in the hours after, depending on your specific treatment protocol. Your chemotherapy nurse will explain your exact schedule before treatment starts. If you are given mesna tablets to take at home, follow the timing instructions carefully — they are part of the bladder protection plan, not an optional addition. If you are unsure about any timing, call your team rather than guessing.

What should I look out for between infusions?

Report any blood in your urine, burning or pain when passing urine, significantly reduced urine output, or signs of infection such as a temperature or unusual shivering. Any confusion, unusual behaviour, or difficulty waking should be reported immediately, not at your next scheduled appointment. Your team will give you written guidance on what to watch for and a contact number for out-of-hours concerns before your first infusion. Use those details — that is exactly what they are provided for.

Worth knowing

Did you know?

Haemorrhagic cystitis — bladder bleeding caused by toxic chemotherapy metabolites — was one of the early dose-limiting complications that restricted the clinical use of ifosfamide.

Mesna was developed specifically to address this. Its routine co-administration with ifosfamide is now a standard recommendation in oncology guidelines, including those from ESMO and ASCO.

Source: ESMO Clinical Practice Guidelines; ASCO Guidelines for Supportive Care in Chemotherapy

Still have a question about your treatment? Tell us what is on your chart and an oncologist will explain what it means for you, what to expect and what your schedule is likely to look like.

Common questions

Frequently asked questions

Is mesna a type of chemotherapy?

No. Mesna has no effect on cancer cells. It is a protective agent given to neutralise a toxic byproduct of ifosfamide called acrolein before it can damage the bladder lining. Its presence in your prescription does not change how ifosfamide works against your cancer — it only reduces the risk of a specific, preventable complication. Some patients receive mesna as part of the same infusion schedule; others also receive tablets to take after leaving hospital. Your team will explain your specific plan.

What is haemorrhagic cystitis and how would I know if I had it?

Haemorrhagic cystitis is inflammation and bleeding in the bladder lining caused by toxic byproducts of certain chemotherapy medicines, including ifosfamide. You would notice blood in your urine — it may look pink, red, or brown — along with a burning sensation or pain when passing urine. These symptoms need to be reported to your treatment team the same day they appear. Mesna is given specifically to prevent this. If you notice any of these signs, do not wait for your next appointment.

How long does ifosfamide-related confusion last?

Ifosfamide-induced encephalopathy is usually temporary and reversible, and it is managed by your medical team. How quickly it clears depends on how severe it is and how promptly it is recognised and treated. Mild episodes often settle within a few days of the problem being addressed. Because the condition can worsen if not treated, any new confusion or unusual behaviour during or after ifosfamide should be reported immediately rather than monitored at home. Your team knows how to assess and manage this.

Which cancers is ifosfamide used for?

Ifosfamide is used for a number of different cancer types, including certain soft tissue sarcomas, bone cancers, testicular cancers, some lymphomas, and certain gynaecological cancers. Where it fits in a treatment plan depends on your specific cancer type, stage, and treatment history. Your oncologist will have explained why this medicine was chosen for your situation. If you are not certain of the reasoning, asking your treating team to go through it with you is entirely reasonable.

Will I need to drink more fluids during ifosfamide treatment?

Your team may ask you to increase your fluid intake during or after ifosfamide infusions, because diluting the urine reduces the concentration of toxic breakdown products that mesna is working to neutralise. The specific guidance depends on your treatment protocol and your kidney function. Follow your team's instructions about fluids rather than general advice — the right amount for you is based on your individual situation. Your team will explain this before treatment starts.

How many days is ifosfamide given over?

Ifosfamide is given by intravenous infusion in a hospital or day-care setting. The schedule — how many days per cycle and how many cycles in total — depends on your cancer type and the specific protocol your oncologist is following. Some protocols deliver it over several consecutive days per cycle; others use a single-day approach. Mesna is given alongside it and sometimes continues as tablets after you leave hospital. Your oncologist and chemotherapy nurse will explain your specific schedule in detail before treatment starts.

Who would be treating you

The medical oncologists on the CION panel

Chemotherapy is prescribed, dosed and supervised by a medical oncologist. These are the six on the CION panel.

Dr. Naresh Gundu, Medical Oncologist at CION Cancer Clinics

Dr. Naresh Gundu

Medical Oncologist

MBBS · DNB Internal Medicine (Sir Gangaram, New Delhi) · DM Medical Oncology (AIIMS)

Dr. C. Raghavendra Reddy, Medical Oncologist at CION Cancer Clinics

Dr. C. Raghavendra Reddy

Medical Oncologist

MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Kukatpally

Dr. Bharati Devi Gorantla, Medical Oncologist at CION Cancer Clinics

Dr. Bharati Devi Gorantla

Medical Oncologist

MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK)

Dr. Owais Mohammed, Medical Oncologist at CION Cancer Clinics

Dr. Owais Mohammed

Medical Oncologist
Dr. T. Raghavender Reddy, Medical Oncologist at CION Cancer Clinics

Dr. T. Raghavender Reddy

Medical Oncologist

MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · L.B. Nagar

Dr. N. Kiranmayee, Medical Oncologist at CION Cancer Clinics

Dr. N. Kiranmayee

Medical Oncologist

Which oncologist you see depends on the centre nearest you and on what your treatment involves. Tell us where you are and we will point you to the closest.

Talk it through

Reading about a medicine is not the same as being told what to expect

This page explains what the medicine does in general. What it cannot tell you is how your own regimen was chosen, what your schedule looks like, or which of these effects apply to you — that needs your reports and a conversation.

Free first consultation Second opinion on an existing plan 10 centres across Hyderabad

Speak to an oncologist

Share your details and the team will call you back to arrange a consultation or a second opinion.

Bring your reports if you have them. If you do not, come anyway.
list of links to other editorial pages, which base contract s2.1 permits explicitly. It contains no form, no phone number and no CTA button, so it does not turn this page into an advertisement. Generated by scripts/hub_update.py --include-out. -->
Full index

Browse all 579 chemotherapy topics

Every page in this section, grouped by the part of treatment it belongs to. Open a group to see what is in it.

Before You Start: Tests, Ports & Fertility42
Blood Counts, Infection, Fever & Emergencies73

Anaemia & Low Haemoglobin

HUB — Low Blood Counts, Infection and Fever During Chemotherapy

Chemotherapy and Supportive Medicines by Name75

Chemotherapy Drugs by Name

HUB — Chemotherapy Drugs by Name

HUB — Generic, Branded and Biosimilar Chemotherapy in India

HUB — Supportive Medicines Used With Chemotherapy

Chemotherapy at CION Cancer Clinics1
Chemotherapy by Cancer Type and Special Situations5

Special Populations & Comorbidities

HUB — Chemotherapy in Special Situations

Chemotherapy in Hyderabad: Cost, Centres & Access93

HUB — Choosing a Chemotherapy Centre and Safe Administration

Common Side Effects and How They Are Managed78
Food, Diet, Hydration & Household Safety6
How Chemotherapy Is Given: Regimens, Cycles & Infusion Days85

Other Ways Chemotherapy Is Given

HUB — Cycles, Schedules and What Happens on Infusion Day

Is It Working, Finishing Chemotherapy & Survivorship7

Is It Working? Response & Scans

HUB — Is Chemotherapy Working? Scans and Response

HUB — When Chemotherapy Stops Working

Nerve, Skin, Heart, Kidney and Cognitive Effects5

Skin, Nails & Hand-Foot Syndrome

Heart, Lung & Organ Toxicity

HUB — Effects on the Heart, Kidneys, Liver and Nerves

Understanding Chemotherapy, Myths & Trials97

HUB — Chemotherapy Myths and Alternative Treatment Claims

HUB — Clinical Trials in Cancer Treatment

HUB — What Is Chemotherapy and Why Has It Been Advised?

Work, Family, Relationships and Emotional Support12
Call now Book free consultation